Skip to content
10-Q

Quarterly Report

Syndax Pharmaceuticals, Inc. SNDX

0000950170-25-101985

← back to feed
Filed
Aug 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 86.14M sh
Shares Diluted Q2 2025 · Jun 30, 2025 86.34M sh
Shares Diluted Q2 2025 · Jun 30, 2025 86.26M sh
Shares Diluted Q2 2025 · Jun 30, 2024 85.27M sh
Shares Diluted Q2 2025 · Jun 30, 2024 85.24M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$182.96M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$155.19M
Short Term Debt Q2 2025 · Jun 30, 2025 $343.85M
Short Term Debt Q2 2025 · Dec 31, 2024 $343.68M
Short Term Investments Q2 2025 · Jun 30, 2025 $346.6M
Short Term Investments Q2 2025 · Dec 31, 2024 $418.8M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $108.64M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $154.08M
Stockholders Equity Q2 2025 · Jun 30, 2025 $157.42M
Stockholders Equity Q2 2025 · Mar 31, 2025 $215.06M
Stockholders Equity Q2 2025 · Dec 31, 2024 $288.12M
Stockholders Equity Q2 2025 · Jun 30, 2024 $434.34M
Stockholders Equity Q2 2025 · Mar 31, 2024 $491.89M
Stockholders Equity Q2 2025 · Dec 31, 2023 $554.2M
Current Liabilities Q2 2025 · Jun 30, 2025 $112.99M
Current Liabilities Q2 2025 · Dec 31, 2024 $103.55M
Total Liabilities Q2 2025 · Jun 30, 2025 $438.73M
Total Liabilities Q2 2025 · Dec 31, 2024 $436.69M
Current Assets Q2 2025 · Jun 30, 2025 $531.68M
Current Assets Q2 2025 · Dec 31, 2024 $603.06M
Total Assets Q2 2025 · Jun 30, 2025 $596.15M
Total Assets Q2 2025 · Dec 31, 2024 $724.82M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.83
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.82
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.80
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.65
Eps Basic Q2 2025 · Jun 30, 2025 −$0.83
Eps Basic Q2 2025 · Jun 30, 2025 −$1.82
Eps Basic Q2 2025 · Jun 30, 2024 −$0.80
Eps Basic Q2 2025 · Jun 30, 2024 −$1.65
Rd Expense Q2 2025 · Jun 30, 2025 $62.23M
Rd Expense Q2 2025 · Jun 30, 2025 $123.86M
Rd Expense Q2 2025 · Jun 30, 2024 $48.66M
Rd Expense Q2 2025 · Jun 30, 2024 $105.15M
Net Income Q2 2025 · Jun 30, 2025 −$71.85M
Net Income Q2 2025 · Jun 30, 2025 −$156.69M
Net Income Q2 2025 · Mar 31, 2025 −$84.85M
Net Income Q2 2025 · Jun 30, 2024 −$68.06M
Net Income Q2 2025 · Jun 30, 2024 −$140.46M
Net Income Q2 2025 · Mar 31, 2024 −$72.4M
Operating Income Q2 2025 · Jun 30, 2025 −$69.35M
Operating Income Q2 2025 · Jun 30, 2025 −$153.11M
Operating Income Q2 2025 · Jun 30, 2024 −$74.22M
Operating Income Q2 2025 · Jun 30, 2024 −$153.73M
Revenue Q2 2025 · Jun 30, 2025 $37.96M
Revenue Q2 2025 · Jun 30, 2025 $57.75M
Revenue Q2 2025 · Jun 30, 2024 $3.5M
Revenue Q2 2025 · Jun 30, 2024 $3.5M